MATINAS BIOPHARMA HOLDINGS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) had Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number of 10.52 million shares as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber · last filed 2026-08-13
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 10.52M shares.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 10.52M shares.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 10.52M shares.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 11.36M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number as first filed |
|---|---|---|
| 2026-06-30 | 10.52M shares 10-Q · filed 2026-08-13 | |
| 2026-03-31 | 10.52M shares 10-Q · filed 2026-05-08 | |
| 2025-12-31 | 10.52M shares 10-Q · filed 2026-08-13 | |
| 2025-09-30 | 11.36M shares 10-Q · filed 2025-11-10 | |
| 2025-06-30 | 11.93M shares 10-Q · filed 2025-08-14 | |
| 2025-03-31 | 6.30M shares 10-Q · filed 2025-05-15 | |
| 2024-12-31 | 666.67K shares 10-Q · filed 2026-08-13 | |
| 2024-09-30 | 666.67K shares 10-Q · filed 2025-11-10 | |
| 2024-06-30 | 666.67K shares 10-Q · filed 2025-08-14 | 33.33M shares 10-Q · filed 2024-08-14 |
| 2023-03-31 | 238.00K shares 10-Q · filed 2023-05-10 | |
| 2022-12-31 | 238.00K shares 10-K · filed 2025-04-15 | 238.00 shares 10-K · filed 2023-03-15 |
| 2022-09-30 | 988.00K shares 10-Q · filed 2022-11-02 | |
| 2022-06-30 | 988.00K shares 10-Q · filed 2022-08-11 | |
| 2022-03-31 | 988.00K shares 10-Q · filed 2022-05-12 | |
| 2021-12-31 | 988.00 shares 10-K · filed 2024-03-27 | 988.00K shares 10-K · filed 2022-03-08 |
| 2021-09-30 | 988.00K shares 10-Q · filed 2021-11-08 | |
| 2021-06-30 | 1.33M shares 10-Q · filed 2021-08-10 | |
| 2021-03-31 | 1.33M shares 10-Q · filed 2021-05-10 | |
| 2020-12-31 | 1.33K shares 10-K · filed 2023-03-15 | 1.33M shares 10-K · filed 2021-03-29 |
| 2020-09-30 | 1.33K shares 10-Q · filed 2020-11-06 | |
| 2020-06-30 | 1.33K shares 10-Q · filed 2020-08-10 | |
| 2019-12-31 | 5.40M shares 10-K/A · filed 2022-03-11 | 5.40K shares 10-Q · filed 2020-08-10 |
| 2018-12-31 | 5.80M shares 10-K · filed 2021-03-29 | 5.80K shares 10-Q · filed 2020-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |